Nurlaila Ika, Rajabto Wulyo, Ningsih Febby Nurdiya, Listiyaningsih Erlin, Ratih Udani Sari
Research Center for Vaccine and Drugs, The National Research and Innovation Agency (BRIN), South Tangerang 15310, Indonesia.
Hematology-Medical Oncology, Department of Internal Medicine, Dr. Cipto Mangunkusumo Hospital/Faculty of Medicine Universitas Indonesia, Jakarta, 10340, Indonesia.
Asian Pac J Cancer Prev. 2025 Jan 1;26(1):225-231. doi: 10.31557/APJCP.2025.26.1.225.
The progress made in cancer immunology has led to the development of innovative therapeutic strategies. However, despite these advances, the superficial characteristics of immune cells have been frequently overlooked: This oversight may be attributed to a limited understanding of the intricate relationships between immune cells and their microenvironment. This study seeks to address this limitation by comprehensively examining cell size and granularity in breast cancer (BC) patients and healthy donors (HD).
Peripheral blood mononuclear cell (PBMC) samples were isolated from BC patients and HD. We examined the size (FSC-A%rCV) and granularity (SSC-A%rCV) of immune cell subsets in both patient groups and HD using flowcytometry.
Despite the absence of statistically significant variations in cell size between BC and HD, visual examination reveals noticeable discrepancies. There is a substantial decrease in granularity in CD8 and CD4 T-cell populations in BC compared to HD which is not observed in B cells.
Our analysis shows that while the size of immune cells may not be significantly altered in breast cancer patients compared to healthy donors, a closer examination of cell granularity reveals a distinct pattern. Specifically, the T-cell populations, including CD8 and CD4 cells, exhibit a substantial decrease in granularity in BC compared to HD. In contrast, B cells remain unaffected, suggesting that the granularity of T cells is uniquely susceptible to perturbations in breast cancer. This observation highlights the importance of considering cell granularity as a critical aspect of immune cell function, particularly in the context of cancer development.
癌症免疫学取得的进展推动了创新治疗策略的发展。然而,尽管有这些进展,免疫细胞的表面特征却常常被忽视:这种忽视可能归因于对免疫细胞与其微环境之间复杂关系的理解有限。本研究旨在通过全面检查乳腺癌(BC)患者和健康供体(HD)的细胞大小和颗粒度来解决这一局限性。
从BC患者和HD中分离外周血单个核细胞(PBMC)样本。我们使用流式细胞术检查了两组患者和HD中免疫细胞亚群的大小(FSC-A%rCV)和颗粒度(SSC-A%rCV)。
尽管BC患者和HD之间的细胞大小没有统计学上的显著差异,但目视检查发现了明显的差异。与HD相比,BC患者的CD8和CD4 T细胞群体的颗粒度大幅下降,而B细胞则未观察到这种情况。
我们的分析表明,虽然与健康供体相比,乳腺癌患者的免疫细胞大小可能没有显著改变,但对细胞颗粒度的进一步检查揭示了一种独特的模式。具体而言,包括CD8和CD4细胞在内的T细胞群体在BC中与HD相比颗粒度大幅下降。相比之下,B细胞未受影响,这表明T细胞的颗粒度在乳腺癌中特别容易受到干扰。这一观察结果突出了将细胞颗粒度视为免疫细胞功能的关键方面的重要性,特别是在癌症发展的背景下。